## **Core Concept**
Aspirin-sensitive asthma, also known as aspirin-exacerbated respiratory disease (AERD), is a condition where patients with asthma experience worsening symptoms after ingesting aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs). This condition is closely related to abnormalities in **arachidonic acid metabolism**, particularly involving the **cyclooxygenase** (COX) pathway.

## **Why the Correct Answer is Right**
The correct answer, **C. Cysteinyl leukotriene overproduction**, is right because AERD is characterized by an abnormal metabolism of arachidonic acid through the COX pathway. In patients with AERD, there is a shunting of arachidonic acid towards the **5-lipoxygenase pathway**, leading to **overproduction of cysteinyl leukotrienes** (LTC4, LTD4, LTE4). These leukotrienes are potent bronchoconstrictors and pro-inflammatory mediators that contribute to the asthma symptoms and nasal polyposis commonly seen in AERD.

## **Why Each Wrong Option is Incorrect**
- **Option A:** While **COX-1 inhibition** by aspirin and other NSAIDs is a trigger for AERD, it is not the underlying association but rather the initiating event.
- **Option B:** **Increased prostaglandin synthesis** is not directly associated with the pathophysiology of AERD. Instead, the issue lies in the diversion of arachidonic acid metabolism towards leukotriene production.
- **Option D:** **Decreased IgE levels** is not a characteristic of AERD. The condition is more related to abnormalities in arachidonic acid metabolism rather than alterations in immunoglobulin levels.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that patients with AERD often present with a triad of **asthma**, **nasal polyposis**, and **sensitivity to aspirin/NSAIDs**. This condition requires careful management, including avoidance of triggering medications and consideration of **leukotriene modifiers** as part of the therapeutic strategy.

## **Correct Answer:** . Cysteinyl leukotriene overproduction